The prognostic value of copeptin in patients with acute chest pain

References

• Heron M. Leading causes for 2010. National vital statistics reports; vol 62 no 6. Hyattsville, MD: National Center for Health Statistics. 2013
   Google Scholar
• WHO. Ten top causes of death. WHO. 2014. Available from: www.who.int/mediacentre/factsheets/fs310/en
   Google Scholar
• Bhuiya F, Pitts S, McCaig L. Emergency department visits for chest pain and abdominal pain: United States 1999-2008. CDC NCHS Data Brief 2010;43
   Google Scholar
• Lindsell CJ, Anantharaman V, Diercks D, et al. The internet tracking registry of acute coronary syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med 2006;48(6):666-77
   PubMed Web of Science ®Google Scholar
• Maisel A, Mueller C, Neath S, et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary Results from the CHOPIN Trial. J Am Coll Cardiol 2013;62:150-60
   PubMed Web of Science ®Google Scholar
• Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60-8
   PubMed Web of Science ®Google Scholar
• Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2012;55:2096-106
   Google Scholar
• Lipinski MJ, Escarcega RO, D’Ascenzo F, et al. A systemic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-rule out of acute myocardial infarction. Am J Cardiol 2014;113(9):1581-91
   PubMed Web of Science ®Google Scholar
• Sebbane M, Lefebvre S, Kuster N, et al. Early rule out of acute myocardial infarction in ED patients: value of combined high-sensitivity cardiac troponin T and ultrasensitive copeptin assays at admission. Am J Emerg Med 2013;31(9):1302-8
   PubMed Web of Science ®Google Scholar
• Elshafei A, Abdalla G, El-Motaal OA, Salman T. Copeptin: a neuroendocrine biomarker in acute myocardial infarction. Annu Rev Res Biol 2013;3(4):1040-54
   Google Scholar
• Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112-19
   PubMed Web of Science ®Google Scholar
• Nickel CH, Bingisser R, Morgenthaler NG. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 2012;10:7
   PubMed Web of Science ®Google Scholar
• Khan SQ, Dhillon OS, O’Brien RJ, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007;115:2103-10
   PubMed Web of Science ®Google Scholar
• Gu YL, Voors AA, Zijlstra F, et al. Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clin Res Cardiol 2011;100:1069-76
   PubMed Web of Science ®Google Scholar
• Thelin J, Borna C, Erlinge D, et al. The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study. BMC Cardiovasc Disord 2013;13(1):42
   Google Scholar
• Afzali D, Erren M, Pavenstadt HJ, et al. Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes. Clin Res Cardiol 2013;102(10):755-63
   Google Scholar
• Reinstadler SJ, Klug G, Feistritzer HJ, et al. Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction. Heart 2013;99(20):1525-9
   Google Scholar
• Voors AA, von Haehling S, Anker SD, et al. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J 2009;30(10):1187-94
   PubMed Web of Science ®Google Scholar
• Narayan H, Dhillon OS, Quinn PA, et al. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study. Clin Sci (Lond) 2011;121(2):79-89
   Google Scholar
• Sanchez M, Llornes P, Herrero P, et al. The utility of copeptin in the emergency department as a predictor of adverse outcomes in non-ST-elevation acute coronary syndrome: the COPED-PAO study. Emerg Med J 2014;31(4):286-91
   Google Scholar
• O’Malley RG, Bonaca MP, Scirica BM, et al. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial. J Am Coll Cardiol 2014;63(16):1644-53
   PubMed Web of Science ®Google Scholar
• Möckel M, Searle J, Hamm C, et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 2014; doi:10.1093/eurheartj/ehu178
   PubMedGoogle Scholar
• Potocki M, Reichlin T, Thalmann S, et al. Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart 2012;98(7):558-65
   PubMed Web of Science ®Google Scholar
• Balimmi C, Meune C, Twerenbold R, et al. Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnosis of acute myocardial infarction and long-term prognosis between women and men. Am Heart J 2013;166(1):30-7
   Google Scholar
• Maisel A, Xue Y, Shah K, et al. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail 2011;4(5):613-20
   PubMed Web of Science ®Google Scholar
• Boeck L, Eggimann P, Smyrnios N, et al. The sequential organ failure assessment score and copeptin for predicting survival in ventilator-associated pneumonia. J Crit Care 2012;27(5):523
   Google Scholar
• Nickel CH, Ruedinger J, Misch F, et al. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med 2011;18(8):851-9
   Google Scholar
• Marston N, Shah K, Mueller C, et al. Copeptin provides prognostic value in patients with acute chest pain. J Am Coll Cardiol 2014;63:12_S
   Google Scholar
• Sukul D, Bonaca MP, Ruff CT, et al. Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain study. Clin Cardiol 2014;37(4):227-32
   Google Scholar